UPDATE: bluebird bio's (BLUE) Zynteglo Gets FDA Approval - List Price In-Line Says Analyst
Tweet Send to a Friend
(Updated - August 17, 2022 4:23 PM EDT)
bluebird bio's (NASDAQ: BLUE) cell-based gene therapy, Zynteglo, has been approved ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
bluebird bio's (NASDAQ: BLUE) cell-based gene therapy, Zynteglo, has been approved ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
